Cilfa Opposition, Levodopa Carbidopa, (Ar103448 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, FXR and PPAR AGONIST, (AR103624A1)
Countries: Argentina Date: 2017
-
CILFA opposition, BACE Inhibitor (LY2886721), (AR103406A1)
Countries: Argentina Date: 2017
-
CILFA opposition, LIXISENATIDE, (AR103415A1)
Countries: Argentina Date: 2017
-
CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)
Countries: Argentina Date: 2017
-
CILFA opposition, AMLODIPINE, LOSARTÁN AND ROSUVASTATINA, (AR098417A1)
Countries: Argentina Date: 2017
-
CILFA opposition, Salmeterol, (AR100687A1)
Countries: Argentina Date: 2017
-
CILFA opposition, LAS191954, (AR100620A1)
Countries: Argentina Date: 2017
-
CILFA opposition, ESTRADIOL - PROGESTERONE, (AR100562A1)
Countries: Argentina Date: 2017
-
CILFA opposition, CERITINIB, (AR100625A1)
Countries: Argentina Date: 2017
-
CILFA opposition, ACETAMINOPHEN - ASPIRIN-IBUPROFEN-NAPROXEN, (AR100515A1)
Countries: Argentina Date: 2017